Eliçin, Olgun; Häfliger, Simon; Dorn, Patrick (May 2024). SAKK 16/18: QA and interim safety of immune-modulatory RT in resectable stage III(N2) NSCLC. Radiotherapy and oncology, 194(1), S1610-S1610. Elsevier
Official URL: https://user-swndwmf.cld.bz/ESTRO-2024-Abstract-Bo...
Item Type: |
Conference or Workshop Item (Poster) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Thoracic Surgery 04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology 04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology |
UniBE Contributor: |
Eliçin, Olgun, Häfliger, Simon, Dorn, Patrick |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0167-8140 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Basak Ginsbourger |
Date Deposited: |
08 Jul 2024 15:28 |
Last Modified: |
08 Jul 2024 15:28 |
URI: |
https://boris.unibe.ch/id/eprint/198653 |
Actions (login required)
 |
Edit item |